Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

31 results about "Actinoplanes sp." patented technology

Actinoplanes utahensis and application thereof in preparing acarbose

The invention discloses Actinoplanes utahensis MYIH97 and application thereof, the strain is preserved by China Center for Type Culture Collection, the preservation number is CCTCC NO:M 2016237, and the preservation date is May 3<rd>, 2016 .The invention further discloses a method for preparing acarbose through fermentation of the strain .For the fermentation process, it is proved through mass production practice that the fermentation unit is high, the impurities are less, the post-extraction difficulty is greatly reduced, the fermentation process is suitable for industrial mass production, and the quality of the obtained acarbose products is high.
Owner:HANGZHOU HUADONG MEDICINE GRP PHARMA RES INST +2

Construction method for streptomycete expression plasmids and production method for keratinase

The invention relates to a construction method for streptomycete expression plasmids and a production method for keratinase. The construction method for streptomycete expression plasmids includes the following steps: a promoter Xi of actinoplanes missouriensis xylose isomerase and a terminator of streptomycete avermitilis amylase are sleeved, and the promoter-shine-dalgarno (SD) sequence comes from 90 to 269bp of an actinoplanes missouriensis xylose isomerase gene; a cloned src family kinases (sfks) gene is inserted in a construction expression frame structure of a synthetic Xi promoter-SD-amyA2 terminator fragment, and then a conventional method is used for constructing the streptomycete expression plasmids. The production method for keratinase includes: leading the streptomycete expression plasmids into an expression host of streptomycete lividans TK24 through conjugal transfer, performing recombinant expression and generating the keratinase. Specific activity of a crude enzyme solution is 1700 U/mg after expression of the expression plasmids in the streptomycete lividans TK24 and is improved by 50 times compared with specific activity of starting strain streptomycete fradiae varieties S-221, and yield of the keratinase is much higher than starting strains after the expression.
Owner:SHANGHAI JIAO TONG UNIV

Preparation method of actinomycetes fibrinolytic enzyme

The invention relates to a preparation method of an actinomycetes fibrinolytic enzyme. Specifically, the method comprises the following steps: (1) adding ammonium sulfate powder to a fermentation supernatant containing actinomycetes fibrinolytic enzyme until a saturation degree is 25-35%W/V, standing by for a whole night at 4 DEG C and centrifuging so as to obtain a supernatant, adding ammonium sulfate powder to the supernatant once again until a saturation degree is 55-65%W/V, standing by for a whole night at 4 DEG C, centrifuging so as to obtain a precipitate, and dissolving the precipitate by virtue of a PB buffer solution so as to obtain crude enzyme liquid; and (2) centrifuging the crude enzyme liquid obtained from the step (1) at low temperature so as to remove impurities; purifying an obtained supernatant subsequently through Octyl-Sepharose FF hydrophobic interaction chromatography and Phenyl-Sepharose HP hydrophobic interaction chromatography so as to obtain a chromatographically pure enzyme; dialyzing and desalting the enzyme, and freeze-drying the enzyme so as to obtain fibrinolytic enzyme freeze-dried powder which can be preserved for a long time at minus 20 DEG C. The separation and purification method of the actinomycetes fibrinolytic enzyme disclosed by the invention has the advantages of simple operation steps and high recovery rate.
Owner:QIQIHAR UNIVERSITY

Method for increasing fermentation unit of acarbose

The invention relates to a method for increasing the fermentation unit of acarbose. The fermentation unit is increased through control of slant strain cultivation conditions of Actinoplanes sp.. Experimental results show that incandescent lamps serve as light sources during slant cultivation of the Actinoplanes sp.; when illumination time is controlled within 12-20h / day and illuminance is controlled within 120-180lux, the fermentation unit can be increased; particularly, when the illumination time is controlled within 12-16h / day and the illuminance is controlled within 150-180lux, the fermentation unit is increased remarkably.
Owner:CSPC SHENGXUE GLUCOSE CO LTD

Method for knocking out negative regulatory protein genes to improve fermentation level of acarbose

ActiveCN112522174AIncreased transcription levels of biosynthetic genesImprove fermentation yieldBacteriaMicroorganism based processesBiosynthetic genesMicrobiology
The invention discloses a method for knocking out negative regulatory genes to improve the fermentation level of acarbose. By adopting the method disclosed by the invention, the negative regulatory protein genes ACPL_5445 and ACPL_3989 are knocked out from actinoplanes to obtain acarbose high-yield mutant strains. By knocking out the negative regulatory protein genes, the expression of acarbose biosynthetic genes can be promoted, and finally the acarbose yield is obviously increased. Compared with an original strain, the high-yield strains obtained by the invention have the advantages that thefermentation yields are improved by 13% and 8%, and the laboratory shake flask fermentation levels reach 3.62 g / L and 3.47 g / L.
Owner:SHANGHAI JIAO TONG UNIV

Deleted high-yield ansamitocin strain and preparation method thereof

The invention provides a deleted high-yield ansamitocin strain and a preparation method thereof, belonging to the technical field of biological medicine. The ansamitocin fermenting level is improved based on the N-glycosyltransferase expression gene of inactivated ansamitocin, and the N-glycosyltransferase expression gene ansa30 inactivated in rare actinosynnema pretiosum ATCC31280, which has 97%homology with the asm25 gene in the rare actinosynnema pretiosum ATCC31565, so that the distribution of ansamitocin bio-synthesis by the method can be reduced, and the ansamitocin yield can be increased. The fermentation final yield of the mutant strain NXJ-22 ansamitocin is increased by 68 percent in comparison with that of a wild strain, and the lab shake flask level reaches 74mg / L.
Owner:辽宁斯韦尔生物科技有限公司 +1

An improved process for the preparation of fidaxomicin

ActiveUS20160083764A1Easy to handleSugar derivativesBacteriaBiotechnologyActinoplanes deccanensis
The present invention provides an improved process for the preparation of fidaxomicin by culturing Actinoplanes deccanensis in the culture medium of the invention wherein the fidaxomicin is produced in a yield of greater than 500 mg / L broth. The present invention also provides a whole broth extraction process for the isolation of fidaxomicin from the fermentation broth. The present invention also provides fidaxomicin having purity of greater than 97% area by HPLC.
Owner:CONCORD BIOTECH

High-yield ansamitocin strain for reinforcing transcriptional level and preparation method thereof

The invention provides a high-yield ansamitocin strain for reinforcing transcriptional level and a preparation method thereof, belonging to the technical field of biological medicine. The yield of ansamitocin can be increased by improving the rate-limiting enzyme gene expression level in biosynthetic pathway. The gene asm10 is modified in the deleted mutant strain NXJ-22 of the glycosyl transferase expression gene of rare actinosynnema pretiosum ATCC31280 after overexpression of strong promoter kasOp*, the methyltransferase activity can be reinforced, and the yield of ansamitocin can be improved. The ansamitocin fermenting final yield of engineering strains is increased by about 173 percent in comparison with that of a control strain, and the lab shaking flask level reaches 141.8mg / L.
Owner:辽宁斯韦尔生物科技有限公司 +1

Methods of use of the enzymes of mycothiol synthesis

The present invention utilizes three families of bacterial enzymes, which play a key role in mycothiol biosynthesis. The three families are bacterial cysteine:glucosaminyl inositol ligases (MshC) with catalytic ligase activity for ligation of glucosaminyl inositol and cysteine, bacterial acetyl-CoA:Cys-GlcN-Ins acetyltransferases (MshD) with catalytic activity for addition of an acetyl group to Cys-GlcN-Ins and bacterial MshA glycosyltransferase with catalytic activity for production of GlcNAc-Ins. The invention provides methods for using the mycothiol biosynthesis ligases, acetyltransferases or glycosyltransferases in drug screening assays to determine compounds that inhibit activity. The invention provides for treatment of actinomycete infections in mammals using antibiotics that inhibit production or activity of the enzymes of mycothiol biosynthesis, in particular MshC, MshD or MshA, and thereby reduce the production of mycothiol and the virulence of the infecting bacteria. Additionally, the invention provides a live mutant with a genome containing a modification in an endogenous enzyme of mycothiol biosynthesis gene. The invention also provides an expression vector comprising polynucleotides of mshA, mshB, mshC and mshD.
Owner:RGT UNIV OF CALIFORNIA +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products